EUVIMEDEUVIMED entdecken
Open Access

Supramolecular immunomodulatory hydrogelator potentiates CAR-T therapy with long-lasting endogenous immunity toward solid tumor eradication

Chenwei Jiang iD, Minglu Tang iD, Mingmei Guo, Qi Shang iD, Qi Chen iD, Xiaoran An, Junjie Xie iD, Kangqi Zheng, Bing Feng iD, Feihu Wang iD

Science Advances · 2026

DOI: 10.1126/sciadv.aee2120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Chenwei Jiang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai 200240, China. Hauptthemen laut MEDLINE: Immunotherapy, Adoptive, Receptors, Chimeric Antigen, Hydrogels, Neoplasms. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Technology Commission of Shanghai Municipal China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The success of chimeric antigen receptor (CAR)-T cell therapy in hematologic malignancies has not been translated to solid tumors, primarily due to inadequate T cell infiltration and an immunosuppressive tumor microenvironment that drives T cell exhaustion. To address these challenges, we developed a tailored immunomodulatory drug-drug conjugate-based hydrogelator for the localized delivery of CAR-T cells targeting solid tumors. This hydrogel forms an in situ scaffold that serves as a sustained-release reservoir, enabling continuous co-delivery of CAR-T cells along with immunomodulatory agents—NLG919 (an IDO-1 inhibitor) and D PPA-1 (a PD-L1 antagonistic peptide)—to synergistically remodel the immunosuppressive tumor microenvironment and promote robust tumor recognition and elimination. Notably, this approach significantly enhances CAR-T cell infiltration and persistence, stimulates a potent endogenous tumor-specific immune response, while also establishing long-lasting immunological memory. In murine models of aggressive melanoma, metastatic breast cancer, and postoperative glioma, a single local administration of the hydrogel resulted in significant suppression of tumor growth, rechallenge, metastasis and recurrence. By integrating localized CAR-T cell delivery with in situ immune reprogramming, this system represents a versatile and clinically translatable platform that substantially improves the efficacy of CAR-T cell therapy against solid tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunotherapy, AdoptiveReceptors, Chimeric AntigenHydrogelsNeoplasmsImmunomodulating AgentsAnimalsMiceHumansTumor MicroenvironmentFemaleCell Line, TumorT-Lymphocytes

Substanzen

Receptors, Chimeric AntigenHydrogelsImmunomodulating Agents

Autor:innen und Institutionen

  • School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai 200240, China.
  • Department of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
  • School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai 200240, China.
  • School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China.
  • Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou 310000, China.

ORCID-Profile: Chenwei Jiang, Minglu Tang, Qi Shang, Qi Chen, Junjie Xie, Bing Feng, Feihu Wang

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Technology Commission of Shanghai Municipal China
  • Key project at central government level: The ability establishment of sustainable use for valuable Chinese medicine resources

Zitieren

APA

Jiang, C., Tang, M., Guo, M., Shang, Q., Chen, Q., An, X., Xie, J., Zheng, K., Feng, B., & Wang, F. (2026). Supramolecular immunomodulatory hydrogelator potentiates CAR-T therapy with long-lasting endogenous immunity toward solid tumor eradication. Science Advances. https://doi.org/10.1126/sciadv.aee2120

Vancouver

Jiang C, Tang M, Guo M, Shang Q, Chen Q, An X, et al. Supramolecular immunomodulatory hydrogelator potentiates CAR-T therapy with long-lasting endogenous immunity toward solid tumor eradication. Science Advances. 2026. doi:10.1126/sciadv.aee2120

BibTeX
@article{Jiang2026,
  author = {Jiang, Chenwei and Tang, Minglu and Guo, Mingmei and Shang, Qi and Chen, Qi and An, Xiaoran and Xie, Junjie and Zheng, Kangqi and Feng, Bing and Wang, Feihu},
  title = {Supramolecular immunomodulatory hydrogelator potentiates CAR-T therapy with long-lasting endogenous immunity toward solid tumor eradication},
  journal = {Science Advances},
  year = {2026},
  doi = {10.1126/sciadv.aee2120}
}
Kostenlos starten →